One Pill Daily May Transform Diabetes Care
A new clinical study has developed an oral medication for type 2 diabetes called Orforglibron, marketed under the name Foundayo. It demonstrates greater effectiveness in reducing blood sugar levels and promoting weight loss compared to existing treatments. It can be taken at any time of day without dietary restrictions. The trials showed an average decrease in HbA1c levels of about 2.2 points and weight loss of up to 9 kilograms over the course of a year, with gastrointestinal side effects similar to those of GLP-1 medications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)